Federation des caisses Desjardins du Quebec’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $546 | Hold |
150
| – | – | ﹤0.01% | 2562 |
|
2025
Q1 | $288 | Hold |
150
| – | – | ﹤0.01% | 2544 |
|
2024
Q4 | $285 | Hold |
150
| – | – | ﹤0.01% | 2434 |
|
2024
Q3 | $198 | Hold |
150
| – | – | ﹤0.01% | 2456 |
|
2024
Q2 | $153 | Hold |
150
| – | – | ﹤0.01% | 2320 |
|
2024
Q1 | $275 | Hold |
150
| – | – | ﹤0.01% | 2283 |
|
2023
Q4 | $186 | Hold |
150
| – | – | ﹤0.01% | 2266 |
|
2023
Q3 | $171 | Hold |
150
| – | – | ﹤0.01% | 2282 |
|
2023
Q2 | $137 | Hold |
150
| – | – | ﹤0.01% | 2260 |
|
2023
Q1 | $84 | Hold |
150
| – | – | ﹤0.01% | 2290 |
|
2022
Q4 | $87 | Hold |
150
| – | – | ﹤0.01% | 2429 |
|
2022
Q3 | $47 | Hold |
150
| – | – | ﹤0.01% | 2483 |
|
2022
Q2 | $53 | Hold |
150
| – | – | ﹤0.01% | 2516 |
|
2022
Q1 | $108 | Hold |
150
| – | – | ﹤0.01% | 2524 |
|
2021
Q4 | $339 | Hold |
150
| – | – | ﹤0.01% | 2480 |
|
2021
Q3 | $432 | Hold |
150
| – | – | ﹤0.01% | 2496 |
|
2021
Q2 | $569 | Hold |
150
| – | – | ﹤0.01% | 2459 |
|
2021
Q1 | $508 | Hold |
150
| – | – | ﹤0.01% | 2396 |
|
2020
Q4 | $420 | Hold |
150
| – | – | ﹤0.01% | 2273 |
|
2020
Q3 | $376 | Hold |
150
| – | – | ﹤0.01% | 2097 |
|
2020
Q2 | $2.04K | Hold |
150
| – | – | ﹤0.01% | 1942 |
|
2020
Q1 | $1.14K | Hold |
150
| – | – | ﹤0.01% | 2055 |
|
2019
Q4 | $948 | Hold |
150
| – | – | ﹤0.01% | 2205 |
|
2019
Q3 | $588 | Hold |
150
| – | – | ﹤0.01% | 2191 |
|
2019
Q2 | $726 | Sell |
150
-470
| -76% | -$2.28K | ﹤0.01% | 2170 |
|
2019
Q1 | $5.08K | Buy |
620
+470
| +313% | +$3.85K | ﹤0.01% | 1803 |
|
2018
Q4 | $830 | Buy |
+150
| New | +$830 | ﹤0.01% | 1968 |
|
2018
Q1 | – | Sell |
-31,161
| Closed | -$462K | – | 2150 |
|
2017
Q4 | $462K | Buy |
31,161
+6,612
| +27% | +$98.1K | 0.01% | 780 |
|
2017
Q3 | $484K | Buy |
+24,549
| New | +$484K | 0.01% | 739 |
|